Literature DB >> 17352298

[Angiography and embolisation to control bleeding after blunt injury to the abdomen or pelvis].

J C Goslings1, O M van Delden.   

Abstract

Angiography and embolisation are being increasingly used to control bleeding following abdominal and pelvic trauma. CT is a useful tool to select patients for such intervention-radiological angiography. The application ofangiography and embolisation requires a specific local infrastructure, logistics and expertise on the part of the radiologist, traumatologist and anaesthetist. The main indications for angiography and embolisation are: contrast blush on the CT scan and clinical signs of ongoing bleeding; they are also indicated as an adjunct to damage control procedures. Angiography and embolisation are successful in about 90% of the patients; complications occur in < 10% of the patients. An accurate estimate of the patient's physical condition, a correct assessment of the severity of the injury, and a multidisciplinary approach are important factors in the success of embolisation therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17352298

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  [Embolization of life-threatening intercostal hemorrhaging in a severely injured patient: a rarity in trauma care].

Authors:  B Hussmann; G Taeger; I Wanke; C Waydhas; B Schoch; D Nast-Kolb; S Lendemans
Journal:  Unfallchirurg       Date:  2009-12       Impact factor: 1.000

Review 2.  Literature review of the role of ultrasound, computed tomography, and transcatheter arterial embolization for the treatment of traumatic splenic injuries.

Authors:  Cornelis H van der Vlies; Otto M van Delden; Bastiaan J Punt; Kees J Ponsen; Jim A Reekers; J Carel Goslings
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-29       Impact factor: 2.740

3.  Utility of Angioembolization in Patients with Abdominal and Pelvic Traumatic Bleeding: Descriptive Observational Analysis from a Level 1 Trauma Center.

Authors:  Hassan Al-Thani; Husham Abdelrahman; Ali Barah; Mohammad Asim; Ayman El-Menyar
Journal:  Ther Clin Risk Manag       Date:  2021-04-19       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.